Material properties and bone marrow stromal cells response to In situ crosslinkable RGD‐functionlized lactide‐co‐glycolide scaffolds
Authors:
- 22 April 2008
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 89A (1) , 124-137
Abstract
In situ crosslinkable biomaterials with degradation profiles that can be tailored to a particular application are indispensable for treating irregularly shaped defects and for fabrication of shape‐selective scaffolds. The objective of this work was to synthesize ultra low molecular weight functionalized PLA and PLGA macromers that can be grafted with bioactive peptides and crosslinked in situ to fabricate biodegradable functional scaffolds. In situ crosslinkable lactide‐co‐glycolide macromer (cMLGA; “c” for crosslinkable, “M” for macromer, and “LGA” for lactide‐co‐glycolide) was synthesized by anionic polymerization of lactide and glycolide monomers followed by condensation polymerization with fumaryl chloride. The cMLA (100% L‐lactide) and cMLGA macromers formed porous crosslinked scaffolds with NVP as the crosslinker. The mass loss of the crosslinked cMLA and cMLGA was linear with incubation time in vitro (zero‐order degradation) and the degradation rate depended on the ratio of lactide to glycolide. cMLGA scaffold with 1:1 lactide to glycolide ratio completely degraded after 4 weeks while the cMLA lost less than 40% of its initial mass after 35 weeks. When cMLA scaffold was functionalized with acrylated integrin‐binding Ac‐GRGD amino acid sequence, bone marrow stromal (BMS) cells attached and spread on the cMLA scaffold and exhibited focal‐point cell adhesion. The mRNA expression levels of collagen‐1α, osteonectin, and osteopontin for BMS cells seeded in the scaffolds with 1 and 5% Ac‐GRGD were upregulated compared with those without Ac‐GRGD. cMLGA is attractive as in situ crosslinkable macromer for fabrication of functional scaffolds with degradation characteristics that can be tailored to a particular application. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009Keywords
This publication has 61 references indexed in Scilit:
- Artificial extracellular matrix proteins contain heparin-binding and RGD-containing domains to improve osteoblast-like cell attachment and growthJournal of Biomedical Materials Research Part A, 2006
- Effects of porosity and pore size on in vitro degradation of three‐dimensional porous poly(D,L‐lactide‐co‐glycolide) scaffolds for tissue engineeringJournal of Biomedical Materials Research Part A, 2005
- Synthesis, Material Properties, and Biocompatibility of a Novel Self-Cross-Linkable Poly(caprolactone fumarate) as an Injectable Tissue Engineering ScaffoldBiomacromolecules, 2005
- Development of a dialysis in vitro release method for biodegradable microspheresAAPS PharmSciTech, 2005
- Skeletal tissue engineering—from in vitro studies to large animal modelsBiomaterials, 2004
- Poly-L-Lactic AcidAmerican Journal of Clinical Dermatology, 2004
- A biodegradable polyurethane‐ascorbic acid scaffold for bone tissue engineeringJournal of Biomedical Materials Research Part A, 2003
- Biodegradable polymeric scaffolds for musculoskeletal tissue engineeringJournal of Biomedical Materials Research, 2001
- Crosslinking characteristics of an injectable poly(propylene fumarate)/?-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cementJournal of Biomedical Materials Research, 1999
- Tissue engineering scaffolds using superstructuresBiomaterials, 1996